Δημοσίευση

I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?

ΤίτλοςI-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Publication TypeJournal Article
Year of Publication2018
AuthorsVerburg, F. A., Giovanella L., Iakovou I., Konijnenberg M. W., Langsteger W., Lassmann M., Mihailovic J., & Luster M.
JournalEur J Nucl Med Mol Imaging
Volume45
Issue13
Pagination2247-2249
Date Published2018 12
ISSN1619-7089
Λέξεις κλειδιάHematologic Neoplasms, Humans, Incidence, Iodine Radioisotopes, Thyroid Neoplasms
Abstract
DOI10.1007/s00259-018-4184-z
Alternate JournalEur J Nucl Med Mol Imaging
PubMed ID30298378

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.